Leadership

Lesley Hill is Mesintel Therapeutics founding Chief Operations Officer. Lesley has led the development of novel fibrosis models and implemented functional genomics screens. She received her BSc from Western University and completed her PhD at the University of British Columbia, focusing on mechanisms of inflammation and their regulation by liver-produced proteins. This was followed by post-doctoral training in Cellular and Physiological Sciences (UBC), investigating fibroblasts in the tumor microenvironment, liver regeneration and fibrosis.